Alpha 2.0
Login Register
» Articles » PMID: 29758087

Pembrolizumab-associated Mucous Membrane Pemphigoid in a Patient with Merkel Cell Carcinoma

Overview
Journal Br J Dermatol
Publisher Oxford University Press
Specialty Dermatology
Date 2018 May 15
PMID 29758087
Citations 13
Authors
V Haug
V Behle
S Benoit
H Kneitz
B Schilling
M Goebeler
A Gesierich
Affiliations
Soon will be listed here.
Citing Articles

The first description of mucous membrane pemphigoid induced by enalapril maleate: a case report.

Xie Y, Zhang Q, Ye L, Wang J, Zeng X, Zhang X BMC Oral Health. 2024; 24(1):1096.

PMID: 39285382 PMC: 11407016. DOI: 10.1186/s12903-024-04865-8.

Oral Toxicities Associated with Immune Checkpoint Inhibitors: Meta-Analyses of Clinical Trials.

Srivastava A, Nogueras-Gonzalez G, Geng Y, Singh J, Myers J, Li Y J Immunother Precis Oncol. 2024; 7(1):24-40.

PMID: 38327757 PMC: 10846637. DOI: 10.36401/JIPO-23-14.

Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experience.

Merli M, Accorinti M, Romagnuolo M, Marzano A, Di Zenzo G, Moro F Front Med (Lausanne). 2023; 10:1208418.

PMID: 37547602 PMC: 10400335. DOI: 10.3389/fmed.2023.1208418.

Cutaneous manifestations associated with immune checkpoint inhibitors.

Watanabe T, Yamaguchi Y Front Immunol. 2023; 14:1071983.

PMID: 36891313 PMC: 9986601. DOI: 10.3389/fimmu.2023.1071983.

A Retrospective, Single-Institution Experience of Bullous Pemphigoid as an Adverse Effect of Immune Checkpoint Inhibitors.

Shalata W, Weissmann S, Gabay S, Sheva K, Abu Saleh O, Abu Jama A Cancers (Basel). 2022; 14(21).

PMID: 36358869 PMC: 9656349. DOI: 10.3390/cancers14215451.